• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素 II 诱导足细胞损伤伴足突融合,其机制与糖酵解减少有关。

Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement.

机构信息

Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China; Nephrology and Urology Research Institute of Wuhan University, Wuhan, China.

Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China; Nephrology and Urology Research Institute of Wuhan University, Wuhan, China.

出版信息

Kidney Int. 2023 Apr;103(4):735-748. doi: 10.1016/j.kint.2023.01.007. Epub 2023 Jan 31.

DOI:10.1016/j.kint.2023.01.007
PMID:36731609
Abstract

Activation of the renin-angiotensin system is associated with podocyte injury and has been well demonstrated as a pivotal factor in the progression of chronic kidney disease. Podocyte energy metabolism is crucial for maintaining their physiological functions. However, whether renin-angiotensin system activation promotes chronic kidney disease progression by disturbing the energy metabolism of podocytes has not been elucidated. Angiotensin II, the main active molecule of the renin-angiotensin system, plays a crucial role in chronic kidney disease initiation and progression, but its impact on podocyte metabolism remains unclear. Here, we demonstrate a rapid decrease in the expression of pyruvate kinase M2, a key glycolytic enzyme, and reduced glycolytic flux in podocytes exposed to angiotensin II in vivo and in vitro. Podocyte-specific deletion of pyruvate kinase M2 in mice aggravated angiotensin II-induced glomerular and podocyte injury with foot process effacement and proteinuria. The inhibition of glycolysis was accompanied by adenosine triphosphate deficiency, cytoskeletal remodeling and podocyte apoptosis. Mechanistically, we found that angiotensin II-induced glycolysis impairment contributed to an insufficient energy supply to the foot process, leading to podocyte injury. Additionally, pyruvate kinase M2 expression was found to be reduced in podocytes from kidney biopsies of patients with hypertensive nephropathy and diabetic kidney disease. Thus, our findings suggest that glycolysis activation is a potential therapeutic strategy for podocyte injury.

摘要

肾素-血管紧张素系统的激活与足细胞损伤有关,并且已被充分证明是慢性肾脏病进展的关键因素。足细胞的能量代谢对于维持其生理功能至关重要。然而,肾素-血管紧张素系统的激活是否通过干扰足细胞的能量代谢来促进慢性肾脏病的进展尚未阐明。血管紧张素 II 是肾素-血管紧张素系统的主要活性分子,在慢性肾脏病的发生和进展中起着关键作用,但它对足细胞代谢的影响尚不清楚。在这里,我们在体内和体外实验中证明,血管紧张素 II 会导致足细胞中关键糖酵解酶丙酮酸激酶 M2 的表达迅速下降,糖酵解通量降低。在小鼠中特异性敲除丙酮酸激酶 M2 会加剧血管紧张素 II 诱导的肾小球和足细胞损伤,导致足突融合和蛋白尿。糖酵解的抑制伴随着三磷酸腺苷缺乏、细胞骨架重塑和足细胞凋亡。在机制上,我们发现血管紧张素 II 诱导的糖酵解损伤导致足突能量供应不足,从而导致足细胞损伤。此外,我们还发现高血压肾病和糖尿病肾病患者肾活检中的足细胞丙酮酸激酶 M2 表达降低。因此,我们的研究结果表明,糖酵解的激活是治疗足细胞损伤的一种潜在治疗策略。

相似文献

1
Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement.血管紧张素 II 诱导足细胞损伤伴足突融合,其机制与糖酵解减少有关。
Kidney Int. 2023 Apr;103(4):735-748. doi: 10.1016/j.kint.2023.01.007. Epub 2023 Jan 31.
2
PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.PKFP 激活可改善糖尿病肾病足细胞足突融合。
Front Endocrinol (Lausanne). 2022 Jan 14;12:797025. doi: 10.3389/fendo.2021.797025. eCollection 2021.
3
Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.糖酵解受损促成糖尿病肾病中足细胞足突融合:鸟氨酸分解代谢的作用
Metabolism. 2022 Sep;134:155245. doi: 10.1016/j.metabol.2022.155245. Epub 2022 Jun 30.
4
Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation.丙酮酸激酶 M2 介导的代谢重编程在足细胞分化中的作用。
Cell Death Dis. 2020 May 11;11(5):355. doi: 10.1038/s41419-020-2481-5.
5
Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin.PKM2 在足细胞中的特异性缺失通过β-连环蛋白减轻 LPS 诱导的足细胞损伤。
Cell Commun Signal. 2022 May 30;20(1):76. doi: 10.1186/s12964-022-00884-6.
6
FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.FHL2 介导高血压肾病足细胞 Rac1 的激活和足突融合。
Sci Rep. 2019 Apr 30;9(1):6693. doi: 10.1038/s41598-019-42328-1.
7
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.丙酮酸激酶M2激活可能预防糖尿病肾小球病变和线粒体功能障碍的进展。
Nat Med. 2017 Jun;23(6):753-762. doi: 10.1038/nm.4328. Epub 2017 Apr 24.
8
Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.葡萄糖通过血管紧张素 II(AngII)依赖性方式特异性调节足细胞中的 TRPC6 表达。
Am J Pathol. 2014 Jun;184(6):1715-26. doi: 10.1016/j.ajpath.2014.02.008. Epub 2014 Apr 13.
9
Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes.Sirt6 缺乏加剧血管紧张素Ⅱ诱导的足细胞胆固醇积累和损伤。
Theranostics. 2020 Jun 12;10(16):7465-7479. doi: 10.7150/thno.45003. eCollection 2020.
10
Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.沉默调节蛋白6缺陷通过靶向Notch信号通路加重足细胞损伤和蛋白尿。
Nat Commun. 2017 Sep 4;8(1):413. doi: 10.1038/s41467-017-00498-4.

引用本文的文献

1
Lactate and lactylation in the kidneys: Current advances and prospects (Review).肾脏中的乳酸与乳酸化:当前进展与展望(综述)
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5562. Epub 2025 Jun 6.
2
Cross Talk Between Macrophages and Podocytes in Diabetic Nephropathy: Potential Mechanisms and Novel Therapeutics.糖尿病肾病中巨噬细胞与足细胞之间的相互作用:潜在机制与新型治疗方法
Mediators Inflamm. 2025 May 2;2025:8140479. doi: 10.1155/mi/8140479. eCollection 2025.
3
The intelligent podocyte: sensing and responding to a complex microenvironment.
智能足细胞:感知并响应复杂的微环境。
Nat Rev Nephrol. 2025 May 8. doi: 10.1038/s41581-025-00965-y.
4
SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂恩格列净通过下调肾小管丙酮酸激酶M2(PKM2)改善糖尿病肾病(DKD)的肾小管间质纤维化。
Cell Mol Life Sci. 2025 Apr 16;82(1):159. doi: 10.1007/s00018-025-05688-8.
5
Investigating the role of gut microbiota in diabetic nephropathy through plasma proteome mediated analysis.通过血浆蛋白质组介导的分析研究肠道微生物群在糖尿病肾病中的作用。
Sci Rep. 2025 Feb 14;15(1):5457. doi: 10.1038/s41598-025-90306-7.
6
CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease.神经酰胺合成酶6将神经酰胺代谢与糖尿病肾病中的固有免疫反应联系起来。
Nat Commun. 2025 Feb 11;16(1):1528. doi: 10.1038/s41467-025-56891-x.
7
G protein-coupled receptor 107 deficiency promotes development of diabetic nephropathy.G蛋白偶联受体107缺陷促进糖尿病肾病的发展。
Mol Biomed. 2025 Feb 11;6(1):10. doi: 10.1186/s43556-025-00250-1.
8
Targeting glycolytic reprogramming by tsRNA-0032 for treating pathological lymphangiogenesis.通过tsRNA-0032靶向糖酵解重编程以治疗病理性淋巴管生成。
Cell Death Dis. 2025 Jan 28;16(1):51. doi: 10.1038/s41419-025-07366-w.
9
T cell metabolism in kidney immune homeostasis.肾脏免疫稳态中的T细胞代谢
Front Immunol. 2024 Dec 16;15:1498808. doi: 10.3389/fimmu.2024.1498808. eCollection 2024.
10
Podocyte SIRPα reduction in diabetic nephropathy aggravates podocyte injury by promoting pyruvate kinase M2 nuclear translocation.糖尿病肾病中足细胞信号调节蛋白α的减少通过促进丙酮酸激酶M2核转位加重足细胞损伤。
Redox Biol. 2024 Dec;78:103439. doi: 10.1016/j.redox.2024.103439. Epub 2024 Nov 20.